ERBB2 and triple-negative breast carcinoma: We identified 44 patients with MBC treated at City of Hope from January 2014 to May 2016 who underwent NGS; 24 triple negative breast cancer (TNBC), 16 estrogen receptor positive (ER+), and 4 human epidermal growth factor receptor 2 positive (HER2+) patients.